Primary Site >> Liver Cancer
Gene >> ALDOB
| 1. | |||||||||||
| Journal: | Vopr Med Khim. 1979 Sep-Oct;25(5):607-11. | ||||||||||
| Title: | [Change in aldolase activity in the organs of mice in the process of hepatoma 22a development]. | ||||||||||
| Author: | Treshchenkova, Iu A | ||||||||||
| PMID: | 494546 | ||||||||||
| 2. | |||||||||||
| Journal: | Hepatology. 2002 Aug;36(2):433-8. | ||||||||||
| Title: | Underexpression of mRNA in human hepatocellular carcinoma focusing on eight loci. | ||||||||||
| Author: | Kinoshita, Moritoshi|Miyata, Masahiko | ||||||||||
| PMID: | 12143053 | ||||||||||
| 3. | |||||||||||
| Journal: | Oncol Rep. 2007 Oct;18(4):943-51. | ||||||||||
| Title: | Identification of differential expression of genes in hepatocellular carcinoma by suppression subtractive hybridization combined cDNA microarray. | ||||||||||
| Author: | Liu, Yuefang|Zhu, Xiaojing|Zhu, Jin|Liao, Shibing|Tang, Qi|Liu, Kaikun|Guan, Xiaohong|Zhang, Jianping|Feng, Zhenqing | ||||||||||
| PMID: | 17786358 | ||||||||||
| 4. | |||||||||||
| Journal: | Oncol Rep. 2008 Apr;19(4):1045-53. | ||||||||||
| Title: | Aberrant expression of the glycolytic enzymes aldolase B and type II hexokinase in hepatocellular carcinoma are predictive markers for advanced stage, early recurrence and poor prognosis. | ||||||||||
| Author: | Peng, Shian-Yang|Lai, Po-Lin|Pan, Hung-Wei|Hsiao, Li-Pin|Hsu, Hey-Chi | ||||||||||
| PMID: | 18357395 | ||||||||||
| 5. | |||||||||||
| Journal: | Arch Toxicol. 2013 Jun;87(6):1001-12. | ||||||||||
| Title: | Inhibition of hepatocyte nuclear factor 1 and 4 alpha (HNF1alpha and HNF4alpha) as a mechanism of arsenic carcinogenesis. | ||||||||||
| Author: | Pastoret, Anna|Marcos, Ricard|Sampayo-Reyes, Adriana|Saucedo-Cardenas, Odila|Lozano-Garza, Gerardo H|Hernandez, Alba | ||||||||||
| PMID: | 23052196 | ||||||||||
| 6. | |||||||||||
| Journal: | Mol Cancer. 2015 Sep 17;14:170. | ||||||||||
| Title: | Aldolase B inhibits metastasis through Ten-Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinoma. | ||||||||||
| Author: | Tao, Qi-Fei|Yuan, Sheng-Xian|Yang, Fu|Yang, Sen|Yang, Yuan|Yuan, Ji-Hang|Wang, Zhen-Guang|Xu, Qing-Guo|Lin, Kong-Ying|Cai, Jie|Yu, Jian|Huang, Wei-Long|Teng, Xiao-Lei|Zhou, Chuan-Chuan|Wang, Fang|Sun, Shu-Han|Zhou, Wei-Ping | ||||||||||
| PMID: | 26376879 | ||||||||||
| 7. | |||||||||||
| Journal: | Dis Markers. 2018 Sep 23;2018:8635329. | ||||||||||
| Title: | Investigating Pathogenic and Hepatocarcinogenic Mechanisms from Normal Liver to HCC by Constructing Genetic and Epigenetic Networks via Big Genetic and Epigenetic Data Mining and Genome-Wide NGS Data Identification. | ||||||||||
| Author: | Li, Cheng-Wei|Chiu, Yu-Kai|Chen, Bor-Sen | ||||||||||
| PMID: | 30344796 | ||||||||||